Dear all,

Come and join us for the 10th Statistics & Biopharmacy conference (SnB 2025) in Paris from Wednesday 8 to Friday 10 October 2025. This unique event brings together statistical experts from industry, academic and regulatory to discuss hot statistical topics in drug development today.

The registration will be closed on the 1st October 2025.

Our exciting conference program includes four plenary sessions: (full program available here )

Session 1 : Modern clinical trials: the challenges of small populations and novel endpoints
- Nigel Stallard (Warwick Medical School): Advances in statistical methods for clinical trials in rare diseases: an overview
- Mia Tackney (MRC, University of Cambridge): Eight Methodological Questions for Digital Outcome Measures

Session 2 & 4 : Use of external information to improve decision making I & II
- Simon Wandel (Novartis): The Good, the Bad and the Ugly: Experiences When Utilizing External Information in Clinical Trials
- Kit Roes (Radboud University Medical Center Nijmegen): Regulatory view on use of external information: Considerations from design to assessment
- Andrea Callegaro (GSK): Covariate-adjusted Robust Mixture Prior approach in clinical trials with historical controls
- Beate Wieseler (IQWiG): Health Techology Assessment view on use of external information

Session 3 : Improving statisticians‘ communication and coding skills
- Daniel Sabanés Bové (RCONIS): Why we Need to Improve Software Engineering in Biostatistics - A Call to Action
- Fanny Chevalier (University of Toronto): Data Insights: Bridging the Gap Between Numbers and Knowledge

There will be also one pre-conference course “Applied Modelling in Drug Development - Flexible regression modelling in Stan via brms” and one post-conference course “Good Software Engineering Practice for R Packages”.

There will be plenty of networking opportunities with other delegates and sponsors during multiple social events.

We look forward to welcoming you in Paris !